Total Reports
1,468
FDA CVM filings
Dog /
2026 FDA CVM data 1,468 reports on file official source
Pointing Dog - Hungarian Short-haired (Vizsla) — FDA Adverse Event Profile
Adverse-event records and label data for Pointing Dog - Hungarian Short-haired (Vizsla) (Dog), sourced from the FDA Center for Veterinary Medicine. Refreshed as new reports are filed. Cite PlainBreed when reusing this analysis.
Pointing Dog - Hungarian Short-haired (Vizsla) (Dog) has 1,468 FDA adverse event reports on record, with 58 deaths reported (400.0% death rate) — ranking #89 by report volume. The most frequently reported reaction is Vomiting (290 cases). The top associated drug is Milbemycin Oxime + Spinosad. Average age at report: 4.7 years.
Deaths Reported
58
of 1,468 reports
Death Rate
400.0%
death-coded share
Avg Age at Report
4.7 yr
23.0 kg avg weight
Death-Coded Outcome Share
Pointing Dog - Hungarian Short-haired (Vizsla) death-coded reports 100.0%
Database median
400.0% of 1,468 reports involved a death outcome. Read alongside breed popularity, veterinary access, and owner awareness — these shape how many events ever reach the FDA. The 12% comparison line is the rough cross-breed median in the FDA CVM database; values above suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 23.0 kg (50.7 lbs)
Top Reported Reactions
Vomiting 290
Lack of efficacy (endoparasite) - hookworm 119
Diarrhoea 110
Lethargy (see also Central nervous system depression in 'Neurological') 99
Emesis 87
Lack of efficacy (endoparasite) - heartworm 80
Digestive tract disorder NOS 78
Seizure NOS 71
Lack of efficacy - NOS 70
INEFFECTIVE, ASCARIDS NOS 48
INEFFECTIVE, HOOKS 46
Other abnormal test result NOS 43
Lack of efficacy (endoparasite) - roundworm NOS 42
Anorexia 40
Emesis (multiple) 36
Most Referenced Drugs
Milbemycin Oxime + Spinosad 237
Ivermectin + Pyrantel As Pamoate Salt 207
Afoxolaner 118
Pyrantel Pamoate;Sarolaner 92
Milbemycin Oxime + Praziquantel 81
Moxidectin 73
Fluralaner Chew Tablets 65
Oclacitinib Maleate 55
Carprofen 51
Spinosad 43
Sarolaner 39
Bedinvetmab 38
Fluralaner 13.64% 12-Week Chew 32
Maropitant Citrate 30
Trilostane 27
Outcome Breakdown
Outcome Unknown
476 (34.5%)
Recovered/Normal
427 (30.9%)
Ongoing
381 (27.6%)
Recovered with Sequela
38 (2.8%)
Euthanized
33 (2.4%)
Died
25 (1.8%)
Gender Distribution
Male 743 (50.6%)
Female 704 (48.0%)
Unknown 17 (1.2%)
Mixed 4 (0.3%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 43 | |
| 2011 | 56 | |
| 2012 | 67 | |
| 2013 | 67 | |
| 2014 | 89 | |
| 2015 | 102 | |
| 2016 | 108 | |
| 2017 | 112 | |
| 2018 | 122 | |
| 2019 | 108 | |
| 2020 | 116 | |
| 2021 | 85 | |
| 2022 | 82 | |
| 2023 | 102 | |
| 2024 | 130 | |
| 2025 | 79 | |
Pointing Dog - Hungarian Short-haired (Vizsla) Pet Health Insights
Across the FDA Center for Veterinary Medicine adverse event database, Pointing Dog - Hungarian Short-haired (Vizsla) accounts for 1,468 submitted reports and currently ranks #89 by report volume within the dog population. Of those reports, 58 involved a death outcome — a 400.0% case-fatality figure calculated directly from the underlying FDA records rather than from external mortality studies. The mean age at time of reporting is 4.7 years, with an average recorded body weight of 23.0 kg (50.7 lbs). These figures reflect the voluntary reporting pool only and should be read alongside breed popularity, veterinary access, and owner awareness — all of which shape how many events ever reach the FDA.
The most frequently reported clinical signs for Pointing Dog - Hungarian Short-haired (Vizsla) are Vomiting (290 reports), Lack of efficacy (endoparasite) - hookworm (119 reports), Diarrhoea (110 reports), together capturing a substantial share of the top-reaction traffic seen in this breed's record. On the product side, Milbemycin Oxime + Spinosad appears in 237 reports and is the single most-referenced drug, followed by Ivermectin + Pyrantel As Pamoate Salt (207) and Afoxolaner (118). Counts like these surface which therapeutic classes dominate the reporting stream — useful context when comparing reactions across breeds of the same dog species.
Outcome coding on the 1,380 reports with a recorded status is dominated by Outcome Unknown (34.5% of coded outcomes). Annual submission volume ranges from 2,010 to 2,025 reports across the 16 years on file, indicating the reporting trend is shaped as much by awareness cycles as by underlying clinical events. Because FDA adverse event reports describe correlation rather than causation, these numbers are most useful as a signal of where to ask further questions with a veterinarian — not as a standalone risk score for any individual dog.
Understanding Pointing Dog - Hungarian Short-haired (Vizsla) Adverse Event Data
Pointing Dog - Hungarian Short-haired (Vizsla) has a moderate volume of adverse event reports (1,468). Report counts are influenced by breed popularity, owner awareness, and veterinary reporting practices.
The 400.0% death rate is above average, though this statistic should be interpreted cautiously. Death reports may be overrepresented because serious outcomes are more likely to be reported than mild reactions.
The most frequently referenced drug in adverse reports is Milbemycin Oxime + Spinosad, appearing in 237 reports. This may indicate widespread use of the medication rather than a specific safety concern for Pointing Dog - Hungarian Short-haired (Vizsla).
Other Dog Breeds
Retriever - Labrador
90,806 reports · 360.0% death rate
Crossbred Canine/dog
68,210 reports · 320.0% death rate
Dog (unknown)
47,381 reports · 870.0% death rate
Retriever - Golden
34,475 reports · 370.0% death rate
Shepherd Dog - German
31,142 reports · 430.0% death rate
Chihuahua
30,657 reports · 420.0% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Pointing Dog - Hungarian Short-haired (Vizsla)? ▼
There are 1,468 adverse event reports involving Pointing Dog - Hungarian Short-haired (Vizsla) in the FDA database, with 58 reports involving death (400.0% death rate). Pointing Dog - Hungarian Short-haired (Vizsla) ranks #89 by report volume.
What are the most common adverse reactions reported for Pointing Dog - Hungarian Short-haired (Vizsla)? ▼
The most commonly reported adverse reactions for Pointing Dog - Hungarian Short-haired (Vizsla) are Vomiting (290 reports), Lack of efficacy (endoparasite) - hookworm (119 reports), Diarrhoea (110 reports), Lethargy (see also Central nervous system depression in 'Neurological') (99 reports), Emesis (87 reports).
What drugs are most frequently associated with Pointing Dog - Hungarian Short-haired (Vizsla) adverse events? ▼
The drugs most frequently referenced in Pointing Dog - Hungarian Short-haired (Vizsla) adverse event reports are Milbemycin Oxime + Spinosad (237 reports), Ivermectin + Pyrantel As Pamoate Salt (207 reports), Afoxolaner (118 reports), Pyrantel Pamoate;Sarolaner (92 reports), Milbemycin Oxime + Praziquantel (81 reports).
What is the average age of Pointing Dog - Hungarian Short-haired (Vizsla) in adverse event reports? ▼
The average age of Pointing Dog - Hungarian Short-haired (Vizsla) at the time of adverse event reports is 4.7 years, with an average weight of 23.0 kg (50.7 lbs).
Does a high number of adverse event reports mean Pointing Dog - Hungarian Short-haired (Vizsla) is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Pointing Dog - Hungarian Short-haired (Vizsla) safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Guides & Resources
Understanding Adverse Events
What FDA reports are and how they are collected
Breed-Specific Risks
Why some breeds appear in more adverse event reports
Pet Medication Safety
Evaluating medication risks using FDA data
Most Reported Medications
Drugs that appear most in adverse event reports
How FDA CVM Tracks Events
The reporting process and database limitations
Related Data Sources
Data Sources & Methodology
Adverse event data sourced from the FDA Center for Veterinary Medicine via the openFDA Animal & Veterinary Adverse Events API. Reports are voluntarily submitted by pet owners, veterinarians, and product manufacturers.
Pointing Dog - Hungarian Short-haired (Vizsla) ranks #89 by total report volume. Death rate (400.0%) reflects the proportion of reports involving death and should not be interpreted as a breed-specific mortality rate. Reporting biases, breed popularity, and veterinary access all influence report counts.
Read our methodology — how this data is sourced, computed, and verified.
Related
Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial